Warning: The NCBI web site requires JavaScript to function. more...
An official website of the United States government
The .gov means it's official. Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you're on a federal government site.
The site is secure. The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.
MRM3 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
GEO DataSets Gene Profile neighbors Chromosome neighbors Homologene neighbors
RWDD4 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
PAFAH1B2 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
BID - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
RPS21 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
PRPF31 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
GEO DataSets Profile neighbors
NME7 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
FAM120AOS - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
GEO DataSets Gene Profile neighbors Chromosome neighbors
SAE1 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
CREBBP - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
MAPK1 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
IDH3G - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
ZFAND2A - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
CHMP2A - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
MIR664B - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
PITRM1 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
PARM1 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
FIP1L1 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
Filters: Manage Filters
Your browsing activity is empty.
Activity recording is turned off.
Turn recording back on